Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Melanoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Immunotherapy
1.4.4 Targeted Therapy
1.4.5 Radiation Therapy
1.5 Market by Application
1.5.1 Global Melanoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Opdivo
1.5.3 Yervoy
1.5.4 Mekinist+Tafinlar
1.5.5 Keytruda
1.5.6 Cotellic
1.5.7 Zelboraf
1.5.8 Imlygic
1.5.9 Generics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Melanoma Therapeutics Market Size
2.2 Melanoma Therapeutics Growth Trends by Regions
2.2.1 Melanoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Melanoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Melanoma Therapeutics Market Size by Manufacturers
3.1.1 Global Melanoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Melanoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Melanoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Melanoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Melanoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Melanoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Melanoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Melanoma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Melanoma Therapeutics Market Size (2014-2019)
5.2 Melanoma Therapeutics Key Players in United States
5.3 United States Melanoma Therapeutics Market Size by Type
5.4 United States Melanoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Melanoma Therapeutics Market Size (2014-2019)
6.2 Melanoma Therapeutics Key Players in Europe
6.3 Europe Melanoma Therapeutics Market Size by Type
6.4 Europe Melanoma Therapeutics Market Size by Application
7 China
7.1 China Melanoma Therapeutics Market Size (2014-2019)
7.2 Melanoma Therapeutics Key Players in China
7.3 China Melanoma Therapeutics Market Size by Type
7.4 China Melanoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Melanoma Therapeutics Market Size (2014-2019)
8.2 Melanoma Therapeutics Key Players in Japan
8.3 Japan Melanoma Therapeutics Market Size by Type
8.4 Japan Melanoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Melanoma Therapeutics Market Size (2014-2019)
9.2 Melanoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Melanoma Therapeutics Market Size by Type
9.4 Southeast Asia Melanoma Therapeutics Market Size by Application
10 India
10.1 India Melanoma Therapeutics Market Size (2014-2019)
10.2 Melanoma Therapeutics Key Players in India
10.3 India Melanoma Therapeutics Market Size by Type
10.4 India Melanoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Melanoma Therapeutics Market Size (2014-2019)
11.2 Melanoma Therapeutics Key Players in Central & South America
11.3 Central & South America Melanoma Therapeutics Market Size by Type
11.4 Central & South America Melanoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Melanoma Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Melanoma Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Amgen, Inc.
12.2.1 Amgen, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Melanoma Therapeutics Introduction
12.2.4 Amgen, Inc. Revenue in Melanoma Therapeutics Business (2014-2019)
12.2.5 Amgen, Inc. Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Melanoma Therapeutics Introduction
12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Melanoma Therapeutics Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Melanoma Therapeutics Introduction
12.4.4 Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2014-2019)
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Melanoma Therapeutics Introduction
12.5.4 Novartis AG Revenue in Melanoma Therapeutics Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 Merck & Co., Inc.
12.6.1 Merck & Co., Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Melanoma Therapeutics Introduction
12.6.4 Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2014-2019)
12.6.5 Merck & Co., Inc. Recent Development
12.7 Daiichi Sankyo Company, Limited
12.7.1 Daiichi Sankyo Company, Limited Company Details
12.7.2 Company Description and Business Overview
12.7.3 Melanoma Therapeutics Introduction
12.7.4 Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2014-2019)
12.7.5 Daiichi Sankyo Company, Limited Recent Development
12.8 AB Sciences
12.8.1 AB Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Melanoma Therapeutics Introduction
12.8.4 AB Sciences Revenue in Melanoma Therapeutics Business (2014-2019)
12.8.5 AB Sciences Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Melanoma Therapeutics Key Market Segments
Table Key Players Melanoma Therapeutics Covered
Table Global Melanoma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Melanoma Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Table Global Melanoma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Opdivo Case Studies
Figure Yervoy Case Studies
Figure Mekinist+Tafinlar Case Studies
Figure Keytruda Case Studies
Figure Cotellic Case Studies
Figure Zelboraf Case Studies
Figure Imlygic Case Studies
Figure Generics Case Studies
Figure Melanoma Therapeutics Report Years Considered
Table Global Melanoma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Melanoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Melanoma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Melanoma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Melanoma Therapeutics Market Share by Regions 2014-2019
Figure Global Melanoma Therapeutics Market Share by Regions 2014-2019
Figure Global Melanoma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Melanoma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Melanoma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Melanoma Therapeutics Market Share by Manufacturers in 2018
Table Global Melanoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Melanoma Therapeutics Product/Solution/Service
Table Date of Enter into Melanoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Melanoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Melanoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Melanoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Melanoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Melanoma Therapeutics Revenue Market Share by Application in 2018
Figure United States Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Melanoma Therapeutics Market Share (2018-2019)
Table United States Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Melanoma Therapeutics Market Share by Type (2014-2019)
Table United States Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Melanoma Therapeutics Market Share by Application (2014-2019)
Figure Europe Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Melanoma Therapeutics Market Share (2018-2019)
Table Europe Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Melanoma Therapeutics Market Share by Type (2014-2019)
Table Europe Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Melanoma Therapeutics Market Share by Application (2014-2019)
Figure China Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Melanoma Therapeutics Market Share (2018-2019)
Table China Melanoma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Melanoma Therapeutics Market Share by Type (2014-2019)
Table China Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Melanoma Therapeutics Market Share by Application (2014-2019)
Figure Japan Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Melanoma Therapeutics Market Share (2018-2019)
Table Japan Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Melanoma Therapeutics Market Share by Type (2014-2019)
Table Japan Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Melanoma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Melanoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Melanoma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Melanoma Therapeutics Market Share by Application (2014-2019)
Figure India Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Melanoma Therapeutics Market Share (2018-2019)
Table India Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Melanoma Therapeutics Market Share by Type (2014-2019)
Table India Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Melanoma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Melanoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Melanoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Melanoma Therapeutics Market Share (2018-2019)
Table Central & South America Melanoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Melanoma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Melanoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Melanoma Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Melanoma Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Amgen, Inc. Company Details
Table Amgen, Inc. Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure Amgen, Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table Amgen, Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Daiichi Sankyo Company, Limited Company Details
Table Daiichi Sankyo Company, Limited Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Company, Limited Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table Daiichi Sankyo Company, Limited Recent Development
Table AB Sciences Company Details
Table AB Sciences Revenue in Melanoma Therapeutics Business (2014-2019)(Million US$)
Figure AB Sciences Revenue Growth Rate in Melanoma Therapeutics Business (2014-2019)
Table AB Sciences Recent Development
Table Global Melanoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Melanoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Melanoma Therapeutics Market Size Share by Regions in 2025
Figure United States Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Melanoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Melanoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Melanoma Therapeutics Market Size by Product (2019-2025)
Figure Global Melanoma Therapeutics Market Size by Product in 2025
Table Global Melanoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Melanoma Therapeutics Market Size by Application (2019-2025)
Figure Global Melanoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources